LIST OF DRUGS, SCHEDULES 1 - V
SCHEDULE 1 DRUGS
Opiates. Unless specifically
excepted or unless listed in another schedule, any of the following opiates,
including their isomers, esters, ethers, salts, and salts of isomers, esters and
ethers, whenever the existence of such isomers, esters, ethers and salts is
possible within the specific chemical designation (for purposes of paragraph (b)(34)
only, the term isomer includes the optical and geometric isomers):
|
(1) Acetyl-alpha-methylfentanyl
(N-[1-(1-methyl-2-phenethyl)-4-piperidinyl]-N-phenylacetamide)
|
9815 |
|
(2) Acetylmethadol
|
9601 |
|
(3) Allylprodine
|
9602 |
|
(4) Alphacetylmethadol
(except levo-alphacetylmethadol also known as levo-alpha-acetylmethadol, levomethadyl
acetate, or LAAM) |
9603 |
|
(5) Alphameprodine
|
9604 |
|
(6) Alphamethadol
|
9605 |
|
(7) Alpha-methylfentanyl
(N-[1-(alpha-methyl-beta-phenyl)ethyl-4-piperidyl] propionanilide;
1-(1-methyl-2-phenylethyl)-4-(N-propanilido) piperidine) |
9814 |
|
(8) Alpha-methylthiofentanyl
(N-[1-methyl-2-(2-thienyl)ethyl-4- piperidinyl]-N-phenylpropanamide) |
9832 |
|
(9) Benzethidine
|
9606 |
|
(10) Betacetylmethadol
|
9607 |
|
(11) Beta-hydroxyfentanyl
(N-[1-(2-hydroxy-2-phenethyl)-4- piperidinyl]-N-phenylpropanamide) |
9830 |
|
(12)
Beta-hydroxy-3-methylfentanyl (other name: N-[1-(2-hydroxy-2- phenethyl)-3-methyl-4-piperidinyl]-N-phenylpropanamide
|
9831 |
|
(13) Betameprodine
|
9608 |
|
(14) Betamethadol
|
9609 |
|
(15) Betaprodine
|
9611 |
|
(16) Clonitazene
|
9612 |
|
(17) Dextromoramide
|
9613 |
|
(18) Diampromide
|
9615 |
|
(19) Diethylthiambutene
|
9616 |
|
(20) Difenoxin
|
9168 |
|
(21) Dimenoxadol
|
9617 |
|
(22) Dimepheptanol
|
9618 |
|
(23) Dimethylthiambutene
|
9619 |
|
(24) Dioxaphetyl
butyrate |
9621 |
|
(25) Dipipanone
|
9622 |
|
(26) Ethylmethylthiambutene
|
9623 |
|
(27) Etonitazene
|
9624 |
|
(28) Etoxeridine
|
9625 |
|
(29) Furethidine
|
9626 |
|
(30) Hydroxypethidine
|
9627 |
|
(31) Ketobemidone
|
9628 |
|
(32) Levomoramide
|
9629 |
|
(33) Levophenacylmorphan
|
9631 |
|
(34) 3-Methylfentanyl (N-[3-methyl-1-(2-phenylethyl)-4-piperidyl]-N-phenylpropanamide) |
9813 |
|
(35) 3-methylthiofentanyl
(N-[(3-methyl-1-(2-thienyl)ethyl-4-piperidinyl]-N-phenylpropanamide) |
9833 |
|
(36) Morpheridine |
9632 |
|
(37) MPPP (1-methyl-4-phenyl-4-propionoxypiperidine) |
9661 |
|
(38) Noracymethadol |
9633 |
|
(39) Norlevorphanol |
9634 |
|
(40) Normethadone |
9635 |
|
(41) Norpipanone |
9636 |
|
(42) Para-fluorofentanyl
(N-(4-fluorophenyl)-N-[1-(2-phenethyl)-4-piperidinyl] propanamide |
9812 |
|
(43) PEPAP
(1-(-2-phenethyl)-4-phenyl-4-acetoxypiperidine |
9663 |
|
(44) Phenadoxone
|
9637 |
|
(45) Phenampromide
|
9638 |
|
(46) Phenomorphan
|
9647 |
|
(47) Phenoperidine
|
9641 |
|
(48) Piritramide
|
9642 |
|
(49) Proheptazine
|
9643 |
|
(50) Properidine
|
9644 |
|
(51) Propiram
|
9649 |
|
(52) Racemoramide
|
9645 |
|
(53) Thiofentanyl
(N-phenyl-N-[1-(2-thienyl)ethyl-4-piperidinyl]-propanamide
|
9835 |
|
(54) Tilidine
|
9750 |
|
(55) Trimeperidine
|
9646 |
Opium derivatives. Unless specifically excepted or unless listed in another
schedule, any of the following opium derivatives, its salts, isomers, and salts
of isomers whenever the existence of such salts, isomers, and salts of isomers
is possible within the specific chemical designation:
|
(1) Acetorphine
|
9319 |
|
(2) Acetyldihydrocodeine
|
9051 |
|
(3) Benzylmorphine
|
9052 |
|
(4) Codeine methylbromide
|
9070 |
|
(5) Codeine-N-Oxide |
9053 |
|
(6) Cyprenorphine
|
9054 |
|
(7) Desomorphine
|
9055 |
|
(8) Dihydromorphine
|
9145 |
|
(9) Drotebanol
|
9335 |
|
(10) Etorphine
(except hydrochloride salt) |
9056 |
|
(11) Heroin |
9200 |
|
(12) Hydromorphinol
|
9301 |
|
(13) Methyldesorphine
|
9302 |
|
(14) Methyldihydromorphine
|
9304 |
|
(15) Morphine methylbromide |
9305 |
|
(16) Morphine methylsulfonate |
9306 |
|
(17) Morphine-N-Oxide |
9307 |
|
(18) Myrophine
|
9308 |
|
(19) Nicocodeine
|
9309 |
|
(20) Nicomorphine
|
9312 |
|
(21) Normorphine
|
9313 |
|
(22) Pholcodine
|
9314 |
|
(23) Thebacon
|
9315 |
Hallucinogenic substances. Unless specifically excepted or unless listed in another schedule,
any material, compound, mixture, or preparation, which contains any quantity of
the following hallucinogenic substances, or which contains any of its salts,
isomers, and salts of isomers whenever the existence of such salts, isomers,
and salts of isomers is possible within the specific chemical designation (for
purposes of this paragraph only, the term "isomer" includes the
optical, position and geometric isomers):
|
(1) Alpha-ethyltryptamine |
7249 |
|
Some trade or other names: etryptamine; Monase;
alpha-ethyl-1H-indole-3-ethanamine; 3-(2-aminobutyl) indole;
alpha-ET; and AET. |
|
|
(2)
4-bromo-2,5-dimethoxy-amphetamine |
7391 |
|
Some trade or other names:
4-bromo-2,5-dimethoxy--alpha-methylphenethylamine;
4-bromo-2,5-DMA |
|
|
(3) 4-Bromo-2,5-dimethoxyphenethylamine |
7392 |
|
Some trade or other names:
2-(4-bromo-2,5-dimethoxyphenyl)-1-aminoethane;
alpha-desmethyl DOB; 2C-B, Nexus. |
|
|
(4) 2,5-dimethoxyamphetamine |
7396 |
|
Some trade or other names: 2,5-dimethoxy-alpha-methylphenethylamine;
2,5-DMA |
|
|
(5)
2,5-dimethoxy-4-ethylamphet-amine |
7399 |
|
Some trade or other names:
DOET |
|
|
(6) 2,5-dimethoxy-4-(n)-propylthiopenenthylamine (2C-T-7), its optical isomers,
salts and salts of isomers |
7348 |
|
(7) 4-methoxyamphetamine |
7411 |
|
Some trade or other names:
4-methoxy-alpha-methylphenethylamine; paramethoxyamphetamine,
PMA |
|
|
(8)
5-methoxy-3,4-mdthylenedioxy-amphetamine |
7401 |
|
(9)
4-methyl-2,5-dimethoxy-amphetamine |
7395 |
|
Some trade and other names:
4-methyl-2,5-dimethoxy-alpha-methylphenethylamine; "DOM"; and
"STP" |
|
|
(10) 3,4-methylenedioxy
amphetamine |
7400 |
|
(11)
3,4-methylenedioxymethamphetamine (MDMA) |
7405 |
|
(12) 3,4-methylenedioxy-N-ethylamphetamine
(also known as N-ethyl-alpha-methyl-3,4(methylenedioxy)phenethylamine, N-ethyl MDA, MDE, MDEA |
7404 |
|
(13)
N-hydroxy-3,4-methylenedioxyamphetamine (also known as
N-hydroxy-alpha-methyl-3,4(methylenedioxy)phenethylamine, and N-hydroxy
MDA |
7402 |
|
(14) 3,4,5-trimethoxy
amphetamine |
7390 |
|
(15) Alpha-methyltryptamine (other name: AMT) |
7432 |
|
(16) Bufotenine |
7433 |
|
Some trade and other names:
3-(beta-Dimethylaminoethyl)-5-hydroxyindole; 3-(2-dimethylaminoethyl)-5-indolol;
N, N-dimethylserotonin;
5-hydroxy-N,N-dimethyltryptamine; mappine |
|
|
(17) Diethyltryptamine |
7434 |
|
Some trade and other names: N,N-Diethyltryptamine; DET |
|
|
(18) Dimethyltryptamine |
7435 |
|
Some trade or other names: DMT |
|
|
(19)
5-methoxy-N,N-diisopropyltryptamine (5-MeO-DIPT), its isomers, salts and
salts of isomers |
7439 |
|
(20) Ibogaine |
7260 |
|
Some trade and other names: 7-Ethyl-6,6
beta;,7,8,9,10,12,13-octahydro-2-methoxy-6,9-methano-5H-pyrido [1', 2':1,2] azepino [5,4-b] indole; Tabernanthe iboga |
|
|
(21) Lysergic acid diethylamide |
7315 |
|
(22) Marihuana |
7360 |
|
(23) Mescaline |
7381 |
|
(24) Parahexyl--7374;
some trade or other names: 3-Hexyl-1-hydroxy-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-dibenzo[b,d]pyran; Synhexyl. |
|
|
7415 |
|
|
Meaning all parts of the plant
presently classified botanically as Lophophora williamsii Lemaire, whether growing
or not, the seeds thereof, any extract from any part of such plant, and every
compound, manufacture, salts, derivative, mixture, or preparation of such
plant, its seeds or extracts (Interprets 21 USC 812(c), Schedule I(c)
(12)) |
|
|
(26) N-ethyl-3-piperidyl benzilate |
7482 |
|
(27) N-methyl-3-piperidyl benzilate |
7484 |
|
(28) Psilocybin |
7437 |
|
(29) Psilocyn |
7438 |
|
7370 |
|
|
Meaning tetrahydrocannabinols
naturally contained in a plant of the genus Cannabis (cannabis plant), as
well as synthetic equivalents of the substances contained in the cannabis
plant, or in the resinous extractives of such plant, and/or synthetic
substances, derivatives, and their isomers with similar chemical structure
and pharmacological activity to those substances contained in the plant, such
as the following: |
|
|
(31) Ethylamine analog of
phencyclidine |
7455 |
|
Some trade or other names:
N-ethyl-1-phenylcyclohexylamine, (1-phenylcyclohexyl)ethylamine,
N-(1-phenylcyclohexyl)ethylamine, cyclohexamine,
PCE |
|
|
(32) Pyrrolidine
analog of phencyclidine |
7458 |
|
Some trade or other names:
1-(1-phenylcyclohexyl)-pyrrolidine, PCPy, PHP |
|
|
(33) Thiophene
analog of phencyclidine |
7470 |
|
Some trade or other names:
1-[1-(2-thienyl)-cyclohexyl]-piperidine,
2-thienylanalog of phencyclidine, TPCP, TCP |
|
|
(34) 1-[1-(2-thienyl)cyclohexyl]pyrrolidine |
7473 |
|
Some other names: TCPy |
|
Depressants. Unless
specifically excepted or unless listed in another schedule,
any material, compound, mixture, or preparation which contains any quantity of
the following substances having a depressant effect on the central nervous
system, including its salts, isomers, and salts of isomers whenever the
existence of such salts, isomers, and salts of isomers is possible within the
specific chemical designation:
|
(1) gamma-hydroxybutyric acid (some other names include GHB; gamma-hydroxybutyrate; 4-hydroxybutyrate; 4-hydroxybutanoic
acid; sodium oxybate; sodium oxybutyrate) |
2010 |
|
(2) Mecloqualone
|
2572 |
|
(3) Methaqualone
|
2565 |
Stimulants. Unless specifically excepted or
unless listed in another schedule, any material, compound, mixture, or
preparation which contains any quantity of the following substances having a
stimulant effect on the central nervous system, including its salts, isomers,
and salts of isomers:
|
(1) Aminorex
(Some other names: aminoxaphen; 2-amino-5-phenyl-2-
oxazoline; or 4,5-dihydro-5-phenly-2-oxazolamine) |
1585 |
|
(2) N-benzylpiperazine
(some other names: BZP; 1-benzylpiperazine), its optical isomers, salts and
salts of isomers |
7493 |
|
(3) Cathinone
|
1235 |
|
Some trade or other names:
2-amino-1-phenyl-1-propanone, alpha-aminopropiophenone,
2-aminopropiophenone, and norephedrone |
|
|
(4) Fenethylline
|
1503 |
|
(5) Methcathinone
(Some other names: 2-(methylamino)-propiophenone; alpha-(methylamino)propiophenone; 2-(methylamino)-1-phenylpropan-1-one;
alpha-N-methylaminopropiophenone; monomethylpropion; ephedrone;
N-methylcathinone; methylcathinone;
AL-464; AL-422; AL-463 and UR1432), its salts, optical isomers and salts of
optical isomers |
1237 |
|
(6) (+/-)cis-4-methylaminorex
((+/-)cis-4,5-dihydro-4-methyl-5-phenyl-2-oxazolamine) |
1590 |
|
(7) N-ethylamphetamine
|
1475 |
|
(8) N,N-dimethylamphetamine
(also known as N,N-alpha-trimethyl-benzeneethanamine;
N,N-alpha-trimethylphenethylamine) |
1480 |
Temporary listing of substances subject
to emergency scheduling. Any material, compound, mixture or preparation
which contains any quantity of the following substances:
|
(1)
N-[1-benzyl-4-piperidyl]-N-phenylpropanamide (benzylfentanyl), its optical isomers, salts and salts of
isomers |
9818 |
|
(2)
N-[1-(2-thienyl)methyl-4-piperidyl]-N-phenylpropanamide
(thenylfentanyl), its optical isolers,
salts and salts of isomers |
9834 |
SCHEDULE II DRUGS
Opium and opiate, and any salt, compound, derivative, or preparation of opium
or opiate excluding apomorphine, thebaine-derived
butorphanol, dextrorphan, nalbuphine, nalmefene, naloxone, and naltrexone, and
their respective salts, but including the following:
|
(1) Raw opium |
9600 |
|
(2) Opium extracts |
9610 |
|
(3) Opium fluid |
9620 |
|
(4) Powdered opium |
9639 |
|
(5) Granulated opium |
9640 |
|
(6) Tincture of opium |
9630 |
|
(7) Codeine |
9050 |
|
9334 |
|
|
9190 |
|
|
9059 |
|
|
(11) Hydrocodone
|
9193 |
|
(12) Hydromorphone
|
9150 |
|
(13) Metopon
|
9260 |
|
(14) Morphine |
9300 |
|
(15) Oxycodone
|
9143 |
|
9652 |
|
|
9333 |
(2) Any salt, compound, derivative, or preparation
thereof which is chemically equivalent or identical with any of the substances
referred to in paragraph
(b) (1) of this section, except that these substances shall not include the
isoquinoline alkaloids of opium.
(3) Opium poppy and poppy straw.
Opiates. Unless specifically excepted or unless in another schedule
any of the following opiates, including its isomers, esters, ethers, salts and
salts of isomers, esters and ethers whenever the existence of such isomers,
esters, ethers, and salts is possible within the specific chemical designation,
dextrorphan and levopropoxyphene
excepted:
|
(1) Alfentanil
|
9737 |
|
(2) Alphaprodine
|
9010 |
|
(3) Anileridine
|
9020 |
|
(4) Bezitramide
|
9800 |
|
(5) Bulk dextropropoxyphene
(non-dosage forms) |
9273 |
|
(6) Carfentanil
|
9743 |
|
(7) Dihydrocodeine
|
9120 |
|
(8) Diphenoxylate
|
9170 |
|
(9) Fentanyl
|
9801 |
|
(10) Isomethadone
|
9226 |
|
(11) Levo-alphacetylmethadol
|
9648 |
|
[Some other names: levo-alpha-acetylmethadol, levomethadyl
acetate, LAAM] |
|
|
(12) Levomethorphan
|
9210 |
|
(13) Levorphanol
|
9220 |
|
(14) Metazocine
|
9240 |
|
(15) Methadone |
9250 |
|
(16)
Methadone-Intermediate, |
9254 |
|
(17) Moramide-Intermediate,
2-methyl-3-morpholino-1, 1-diphenylpropane-carboxylic acid |
9802 |
|
(18) Pethidine
(meperidine) |
9230 |
|
(19) Pethidine-Intermediate-A,
4-cyano-1-methyl-4-phenylpiperidine |
9232 |
|
(20) Pethidine-Intermediate-B,
ethyl-4-phenylpiperidine-4-carboxylate |
9233 |
|
(21) Pethidine-Intermediate-C,
1-methyl-4-phenylpiperidine-4-carboxylic acid |
9234 |
|
(22) Phenazocine
|
9715 |
|
(23) Piminodine
|
9730 |
|
(24) Racemethorphan
|
9732 |
|
(25) Racemorphan
|
9733 |
|
(26) Remifentanil
|
9739 |
|
(27) Sufentanil
|
9740 |
Stimulants. Unless specifically excepted or
unless listed in another schedule, any material, compound, mixture, or
preparation which contains any quantity of the following substances having a
stimulant effect on the central nervous system:
|
(1) Amphetamine, its salts,
optical isomers, and salts of its optical isomers |
1100 |
|
(2) Methamphetamine, its salts,
isomers, and salts of its isomers |
1105 |
|
(3) Phenmetrazine
and its salts |
1631 |
|
(4) Methylphenidate |
1724 |
Depressants. Unless
specifically excepted or unless listed in another
schedule, any material, compound, mixture, or preparation which contains any
quantity of the following substances having a depressant effect on the central
nervous system, including its salts, isomers, and salts of isomers whenever the
existence of such salts, isomers, and salts of isomers is possible within the
specific chemical designation:
|
(1) Amobarbital
|
2125 |
|
(2) Glutethimide
|
2550 |
|
(3) Pentobarbital |
2270 |
|
(4) Phencyclidine |
7471 |
|
(5) Secobarbital
|
2315 |
|
(1) Nabilone
|
7379 |
|
[Another name for nabilone:
(+/-)-trans-3-(1,1-dimethylheptyl)-6,6a,7,8,10,10a-hexahydro-1-hydroxy-6, |
|
(g) Immediate precursors. Unless
specifically excepted or unless listed in another
schedule, any material, compound, mixture, or preparation which contains any
quantity of the following substances:
(1) Immediate precursor to amphetamine and methamphetamine:
|
(i) Phenylacetone |
8501 |
|
Some trade or other names:
phenyl-2-propanone; P2P; benzyl methyl ketone; |
|
(2) Immediate precursors to
phencyclidine (PCP):
|
(i) 1-phenylcyclohexylamine |
7460 |
|
(ii)
1-piperidinocyclohexanecarbonitrile (PCC) |
8603 |
SCHEDULE III DRUGS
Stimulants. Unless specifically excepted or unless listed in another schedule,
any material, compound, mixture, or preparation which contains any quantity of
the following substances having a stimulant effect on the central nervous sxstem, including its salts, isomers (whether optical,
position, or geometric), and salts of such isomers whenever the existence of
such salts, isomers, and salts of isomers is possible within the specific
chemical designation:
|
(1) Those compounds,
mixtures, or preparations in dosage unit form containing any stimulant
substances listed in schedule II which compounds, mixtures, or preparations
were listed on August 25, 1971, as excepted compounds under Sec.
1308.32, and any other drug of the quantitative composition shown in that
list for those drugs or which is the same except that it contains a lesser
quantity of controlled substances |
1405 |
|
(2) Benzphetamine
|
1228 |
|
(3) Chlorphentermine
|
1645 |
|
(4) Clortermine
|
1647 |
|
(5) Phendimetrazine
|
1615 |
Depressants. Unless specifically excepted or
unless listed in another schedule, any material, compound, mixture, or
preparation which contains any quantity of the following substances having a
depressant effect on the central nervous system:
|
(1) Any compound, mixture
or preparation containing:
|
|||||||
|
(2) Any suppository dosage form
containing:
|
|||||||
|
(3) Any substance which contains
any quantity of a derivative of barbituric acid or
any salt thereof |
2100 |
||||||
|
(4) Chlorhexadol
|
2510 |
||||||
|
(5) Any drug product containing
gamma hydroxybutyric acid, including its salts,
isomers, and salts of isomers, for which an application is approved under
section 505 of the Federal Food, Drug, and Cosmetic Act |
2012 |
||||||
|
(6) Ketamine,
its salts, isomers, and salts of isomers |
7285 |
||||||
|
[Some other names for ketamine: (+)-2-(2-chlorophenyl)-2-(methylamino)-cyclohexanone] |
|||||||
|
(7) Lysergic acid |
7300 |
||||||
|
(8) Lysergic acid amide |
7310 |
||||||
|
(9) Methyprylon
|
2575 |
||||||
|
(10) Sulfondiethylmethane
|
2600 |
||||||
|
(11) Sulfonethylmethane
|
2605 |
||||||
|
(12) Sulfonmethane
|
2610 |
||||||
|
(13) Tiletamine
and zolazepam or any salt thereof |
7295 |
||||||
|
Some trade or other names for a tiletamine-zolazepam combination product: Telazol |
|||||||
(d) Nalorphine 9400.
Narcotic Drugs. Unless specifically excepted or
unless listed in another schedule:
(1) Any material, compound, mixture, or preparation containing
any of the following narcotic drugs, or their salts calculated as the free
anhydrous base or alkaloid, in limited quantities as set forth below:
|
(i) Not more than
1.8 grams of codeine per 100 milliliters or not more than 90 milligrams per
dosage unit, with an equal or greater quantity of an isoquinoline
alkaloid of opium |
9803 |
|
(ii) Not more than 1.8 grams of
codeine per 100 milliliters or not more than 90 milligrams per dosage unit,
with one or more active, nonnarcotic ingredients in
recognized therapeutic amounts |
9804 |
|
(iii) Not more than 300
milligrams of dihydrocodeinone (hydrocodone)
per 100 milliliters or not more than 15 milligrams per dosage unit, with a
fourfold or greater quantity of an isoquinoline
alkaloid of opium |
9805 |
|
(iv) Not more than 300
milligrams of dihydrocodeinone (hydrocodone)
per 100 milliliters or not more than 15 milligrams per dosage unit, with one
or more active nonnarcotic ingredients in
recognized therapeutic amounts |
9806 |
|
(v) Not more than
1.8 grams of dihydrocodeine per 100 milliliters or
not more than 90 milligrams per dosage unit, with one or more active nonnarcotic ingredients in recognized therapeutic amounts
|
9807 |
|
(vi) Not more than
300 milligrams of ethylmorphine per 100 milliliters
or not more than 15 milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts
|
9808 |
|
(vii) Not more
than 500 milligrams of opium per 100 milliliters or per 100 grams or not more
than 25 milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts |
9809 |
|
(viii) Not more than 50
milligrams of morphine per 100 milliliters or per 100 grams, with one or more
active, nonnarcotic ingredients in recognized
therapeutic amounts |
9810 |
(2) Any material, compound, mixture, or preparation
containing any of the following narcotic drugs or their salts, as set forth
below:
|
(i) Buprenorphine |
9064 |
Anabolic steroids. Unless specifically excepted or unless
listed in another schedule, any material, compound, mixture, or preparation
containing any quantity of the following substances, including its salts,
isomers, and salts of isomers whenever the existence of such salts of isomers
is possible within the specific chemical designation:
|
(1) Anabolic Steroids |
4000 |
Hallucinogenic substances.
|
(1) Dronabinol
(synthetic) in sesame oil and encapsulated in a soft gelatin capsule in a
U.S. Food and Drug Administration approved product |
7369 |
|
[Some other names for dronabinol: (6aR-trans)-6a,7,8,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo
[b,d]pyran-1-ol] or (-)-delta-9-(trans)-tetrahydrocannabinol |
|
SCHEDULE IV DRUGS
Narcotic drugs. Unless
specifically excepted or unless listed in another
schedule, any material, compound, mixture, or preparation containing any of the
following narcotic drugs, or their salts calculated as the free anhydrous base
or alkaloid, in limited quantities as set forth below:
|
(1) Not more than 1
milligram of difenoxin and not less than
25 |
9167 |
|
(2) Dextropropoxyphene
(alpha-(+)-4-dimethylamino-1,2-diphenyl-3-methyl-2-propionoxybutane) |
9278 |
Depressants. Unless specifically excepted or
unless listed in another schedule, any material, compound, mixture, or
preparation which contains any quantity of the following substances, including
its salts, isomers, and salts of isomers whenever the existence of such salts,
isomers, and salts of isomers is possible within the specific chemical
designation:
|
(1) Alprazolam |
2882 |
|
(2) Barbital |
2145 |
|
(3) Bromazepam
|
2748 |
|
(4) Camazepam
|
2749 |
|
(5) Chloral betaine |
2460 |
|
(6) Chloral hydrate |
2465 |
|
(7) Chlordiazepoxide
|
2744 |
|
(8) Clobazam
|
2751 |
|
(9) Clonazepam
|
2737 |
|
(10) Clorazepate
|
2768 |
|
(11) Clotiazepam
|
2752 |
|
(12) Cloxazolam
|
2753 |
|
(13) Delorazepam
|
2754 |
|
(14) Diazepam |
2765 |
|
2467 |
|
|
(16) Estazolam
|
2756 |
|
(17) Ethchlorvynol
|
2540 |
|
(18) Ethinamate
|
2545 |
|
(19) Ethyl loflazepate
|
2758 |
|
(20) Fludiazepam
|
2759 |
|
(21) Flunitrazepam
|
2763 |
|
(22) Flurazepam
|
2767 |
|
(23) Halazepam
|
2762 |
|
(24) Haloxazolam
|
2771 |
|
(25) Ketazolam
|
2772 |
|
(26) Loprazolam
|
2773 |
|
(27) Lorazepam
|
2885 |
|
(28) Lormetazepam
|
2774 |
|
(29) Mebutamate
|
2800 |
|
(30) Medazepam
|
2836 |
|
(31) Meprobamate
|
2820 |
|
(32) Methohexital
|
2264 |
|
(33) Methylphenobarbital
(mephobarbital) |
2250 |
|
(34) Midazolam
|
2884 |
|
(35) Nimetazepam
|
2837 |
|
(36) Nitrazepam
|
2834 |
|
(37) Nordiazepam
|
2838 |
|
(38) Oxazepam |
2835 |
|
(39) Oxazolam |
2839 |
|
(40) Paraldehyde |
2585 |
|
(41) Petrichloral |
2591 |
|
(42) Phenobarbital |
2285 |
|
(43) Pinazepam |
2883 |
|
(44) Prazepam |
2764 |
|
(45) Quazepam |
2881 |
|
(46) Temazepam |
2925 |
|
(47) Tetrazepam |
2886 |
|
(48) Triazolam |
2887 |
|
(49) Zaleplon |
2781 |
|
(50) Zolpidem |
2783 |
Fenfluramine.
Any material, compound, mixture, or preparation which contains any quantity of
the following substances, including its salts, isomers (whether optical, position,
or geometric), and salts of such isomers, whenever the existence of such salts,
isomes, and salts of isomers is possible:
|
(1) Fenfluramine
|
1670 |
Stimulants. Unless specifically excepted or unless
listed in another schedule, any material, compound, mixture, or preparation
which contains any quantity of the following substances having a stimulant
effect on the central nervous system, including its salts, isomers and salts of
isomers:
|
(1) Cathine
((+)-norpseudoephedrine) |
1230 |
|
(2) Diethylpropion
|
1610 |
|
(3) Fencamfamin
|
1760 |
|
(4) Fenproporex
|
1575 |
|
(5) Mazindol
|
1605 |
|
(6) Mefenorex
|
1580 |
|
(7) Modafinil |
1680 |
|
(8) Pemoline
(including organometallic complexes and chelates thereof) |
1530 |
|
(9) Phentermine
|
1640 |
|
(10) Pipradrol
|
1750 |
|
(11) Sibutramine
|
1675 |
|
(12) SPA ((-)-1-dimethylamino-
1,2-diphenylethane) |
1635 |
(f) Other substances. Unless specifically excepted or unless listed in another schedule, any material,
compound, mixture or preparation which contains any quantity of the following
substances, including its salts:
Pentazocine 9709
Butorphanol
(including its optical isomers) 9720
SCHEDULE V
DRUGS
Narcotic drugs. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation containing any of the following narcotic drugs and their salts, as set forth below:
(1) Not more than 200 milligrams of codeine
per 100 milliliters or per 100 grams.
(2) Not more than 100 milligrams
of dihydrocodeine per 100 milliliters or per 100
grams.
(3) Not more than 100 milligrams
of ethylmorphine per 100 milliliters or per 100
grams.
(4) Not more than 2.5 milligrams of
diphenoxylate and not less than 25 micrograms of
atropine sulfate per dosage unit.
(5) Not more than 100 milligrams
of opium per 100 milliliters or per 100 grams.
(6) Not more than 0.5 milligram of
difenoxin and not less than 25 micrograms of atropine
sulfate per dosage unit.
(d) Stimulants. Unless
specifically exempted or excluded or unless listed in another schedule, any
material, compound, mixture, or preparation which contains any quantity of the
following substances having a stimulant effect on the central nervous system,
including its salts, isomers and salts of isomers:
(1) Pyrovalerone 1485